ImmunoGen shares are trading higher after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash

1150

benzinga

2023-11-30T15:19:20-0500

ImmunoGen shares are trading higher after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash

#1 Morning Stock Show To Get You Ready For The Stock Market Open, PreMarket Gainers, Earnings This Week, Economic Data & More! Benzinga PreMarket Prep 8:00AM ET- 9:00AM ET

day tradingbenzingaday traderstock marketstocksswing tradingoptions tradingstock market newsmergerearningsmoneyinvestmentbusinessinvestingfinancial newsNASDAQNYSEinvestorWall Streetstocks to watchstock market investingfinanceAcquisitionwealth buildingAbbVieIMGNImmunoGen